SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-005578
Filing Date
2015-07-13
Accepted
2015-07-10 17:51:33
Documents
4
Period of Report
2015-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501582_8k.htm 8-K 21134
2 EXHIBIT 5.1 t1501582_ex5-1.htm EX-5.1 10371
3 EXHIBIT 10.1 t1501582_ex10-1.htm EX-10.1 249462
4 GRAPHIC ex5-1logo.jpg GRAPHIC 5404
  Complete submission text file 0001571049-15-005578.txt   289804
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 15984451
SIC: 2834 Pharmaceutical Preparations